Envestnet Asset Management Inc G1 Therapeutics, Inc. Transaction History

Envestnet Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$2.2 - $4.98 $268 - $607	-122 Reduced 0.34%	35,299 $80,000
Q1 2024 May 13, 2024	BUY	$2.1 - $4.83 $16,254 - $37,384	7,740 Added 27.96%	35,421 $153,000
Q4 2023 Feb 13, 2024	BUY	$1.12 - $3.73 $3,653 - $12,167	3,262 Added 13.36%	27,681 $84,000
Q3 2023 Nov 13, 2023	BUY	$1.22 - $2.67 $5,521 - $12,084	4,526 Added 22.75%	24,419 $35,000
Q2 2023 Aug 04, 2023	BUY	$2.46 - $3.14 $8,669 - $11,065	3,524 Added 21.53%	19,893 $49,000
Q1 2023 May 11, 2023	BUY	$2.57 - $8.16 $15,358 - $48,764	5,976 Added 57.5%	16,369 $43,000
Q4 2022 Feb 07, 2023	BUY	$5.19 - $13.5 $53,939 - $140,305	10,393 New	10,393 $56,000
Q2 2022 Aug 03, 2022	BUY	$4.04 - $8.51 $43,518 - $91,669	10,772 New	10,772 $53,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.